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In the dog, implantation takes place at approximately 17 days of embryonal life and, while
exposed to relatively high circulating progesterone concentrations, embryos presence
is required for the formation of decidua. Furthermore, a balance between pro- and
anti-inflammatory responses in conceptus-maternal communication is crucial for the
onset of pregnancy. Strikingly, the understanding of such immune mechanisms in
canine reproduction is still elusive. Here, canine uterine samples from pre-implantation
(day 10–12, E+) and corresponding non-pregnant controls (E–), implantation (day 17,
Imp) and post-implantation (day 18–25, Post-Imp) stages of pregnancy were used to
investigate the expression and localization of several immune-related factors. The most
important findings indicate increased availability of CD4, MHCII, NCR1, IDO1, AIF1,
CD25, CCR7, and IL6 in response to embryo presence (E+), while FoxP3 and CCL3
were more abundant in E– samples. Implantation was characterized by upregulated
levels of FoxP3, IL12a, ENG, and CDH1, whereas CD4, CCR7, IL8, and -10 were
less represented. Following implantation, decreased transcript levels of TNFR1, MHCII,
NCR1, TLR4, CD206, FoxP3, and IL12a were observed concomitantly with the highest
expression of IL6 and IL1β. MHCII, CD86, CD206, CD163, TNFα, IDO1, and AIF1 were
immunolocalized in macrophages, CD4 and Nkp46 in lymphocytes, and some signals of
IDO1, AIF1, and TNF-receptors could also be identified in endothelial cells and/or uterine
glands. Cumulatively, new insights regarding uterine immunity in the peri-implantation
period are provided, with apparent moderated pro-inflammatory signals prevailing
during pre-implantation, while implantation and early trophoblast invasion appear to be
associated with immunomodulatory and rather anti-inflammatory conditions.
Keywords: dog (Canis lupus familiaris), immune system, uterus, early pregnancy, embryo-maternal
communication
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INTRODUCTION
The uterine mucosal immune system plays an important role
during maternal recognition and establishment of pregnancy.
This is accomplished by maintaining a balance between
the defense against pathogens and the tolerance toward the
allogeneic sperm and semiallogeneic embryo, adapting thereby
to different pregnancy-associated events (e.g., implantation,
placentation, parturition) and contributing to tissue remodeling
(1–3). This balance relies on the complex population of resident
immune cells, composed of, e.g., macrophages, natural killer
(NK) cells, B and T lymphocytes, regulated by local and
systemic signaling, including endocrine insults (1, 2, 4, 5),
and changing during the progression of pregnancy. This, i.e.,
regards the polarization of uterine macrophages. Thus, as shown
e.g., in humans, pre-implantation is marked by a predominant
presence of M1 (pro-inflammatory) macrophages, transitioning
to a mixed, M1/M2, population during trophoblast attachment
and a predominant presence of M2 macrophages following
placentation [reviewed in (6)]. While the role of all of the
different immune cell populations in the uterus is not fully
understood, some, like the NK are crucial in the onset of
pregnancy. In the human and mouse uterus they are required
for the formation of highly invasive (hemochorial) deciduate
placenta [reviewed in (7, 8)]. NK cells are the most prevalent
immune cell population in the uterus in these species and are
involved in the regulation of trophoblast invasion, playing key
roles in the remodeling of spiral arterioles during the formation
of decidual tissue [reviewed in (8)]. However, despite presenting
a deciduate endotheliochorial placenta, no such mechanisms are
known for the dog, nor has the composition of the immune
system been thoroughly studied in this species.
Furthermore, translational research from other species to
the dog is limited by the canine species-specific decidualization
mechanisms as a part of the peculiar reproductive physiology.
Thus, lacking an active luteolytic event, non-pregnant bitches
present a physiological pseudopregnancy that lasts frequently
longer than pregnancy, with luteal P4 circulating levels similar
to those observed in pregnant animals [reviewed in (9)].
Additionally, canine oocytes require oviductal maturation
to reach fertilization competence, while implantation and
development of a decidual endotheliochorial placenta start
around days 17–18 after fertilization (10–12). Despite the
high P4 levels observed during this period, no spontaneous
decidualization can be observed in non-pregnant bitches, as
the presence of the implanting blastocyst is needed to induce
the differentiation of maternal stromal cells into decidual cells
[reviewed in (13)]. Nevertheless, while the presence of an
embryo-derived antiluteolytic signal is not needed in this species,
cross-talk between the embryo and maternal tissue is still
required for the establishment of pregnancy. Indeed, the presence
of free-floating blastocysts has been associated with changes
in the uterine transcriptome indicating modulation of, e.g.,
extracellular matrix components and immune system-related
factors (14–16).
However, with regard to the involvement of the immune
system in the establishment of pregnancy, available information
for the dog pales in contrast to what is known for other species
with a deciduate placenta. Canine early pregnancy is associated
with increased circulating levels of acute phase and heat shock
proteins that, due to their high sensitivity to the health status of
the animal, have limited use asmarkers of pregnancy [reviewed in
(13)]. As for embryo-induced changes, earlier qualitative analyses
of the pre-implantation uterine immune milieu in pregnant and
pseudopregnant bitches described differences in the presence
of factors like CD4, CD8, INFγ, TNFα, and some interleukins
(17, 18). In a later study from our group, the presence of free-
floating embryos was associated with the predicted activation
of signaling pathways involving IL1, IL10, toll-like receptor
(TLR) and NFκB, and increased expression of chemokines and
other immune regulators (14). As for the period of implantation
and placentation, the available information is limited to the
observed increased availability of leukemia inhibitory factor
(LIF) and macrophage colony-stimulating (MCS) factor in
placentation sites, in contrast with early pregnancy (17, 19).
Furthermore, while immunohistochemical description of CD3+
T lymphocytes, macrophages and B lymphocytes is available
for non-pregnant bitches (20), nothing is known regarding the
uterine immune population of pregnant animals.
Consequently, while the immune system plays an important
role in the onset of pregnancy, there is only scarce information
available for the dog. To address this knowledge gap, the aim
of this study was to characterize factors constituting the uterine
immune milieu during the early stages of canine pregnancy,
i.e., during the free-floating embryo stage (pre-implantation),
at the time of implantation (day 17) and during placental
formation (post-implantation). We investigated the expression
and/or localization of twenty four different immune factors that
serve as markers of different immune cells subsets and/or are
involved in immune regulation. In addition, gene expression
of six factors involved in tissue growth and remodeling was
also evaluated.
MATERIALS AND METHODS
Tissue Collection and Preservation
Uterine- and utero-placental samples from 27 (n = 27) healthy,
mixed breed bitches aged 2–8 years old were allotted to the
present work. All samples had been used before and details
on animal manipulation and determination of pregnancy status
were described in (14, 21–23). Briefly, animals were monitored
for the onset of spontaneous ovulation by vaginal cytology
and progesterone (P4) measurements. Health condition of the
animals was evaluated by routine clinical examination. P4 levels
were determined by radioimmunoassay, as previously described
(24). Ovulationwas considered to have occurred when circulating
levels of P4 exceeded 5 ng/ml, and bitches were mated 2–3 days
later (time needed for oocyte maturation and completion of
the first meiotic division). Day of mating was considered day 0
of pregnancy. Samples were collected by ovariohysterectomy at
different pregnancy stages: pre-implantation (days 8–12, before
embryo apposition), at the day of implantation (Imp, day 17,
n = 5) and during early placentation (post-implantation stage,
Post-Imp, days 18–25, n = 5). During pre-implantation, early
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pregnancy was confirmed by uterine flushing and recovery of
embryos (E+, n= 9). Animals in which no embryo was recovered
between days 8–12 were considered not pregnant (E-, n =
8). Following surgery, retrieved uterine samples (including all
histological layers) were immediately trimmed of connective
tissues and washed in cold PBS. From Imp and Post-Imp
groups, implantation/placentation sites were collected (the Post-
Imp stage included the early utero-placental formation). For
RNA analysis, samples were immersed in RNAlater (Ambion
Biotechnology GmbH, Wiesbaden, Germany) for 24 h at 4◦C
and then stored at −80◦C until used for RNA isolation. For
histological analysis, samples were fixed for 24 h in 10% neutral
phosphate-buffered formalin, washed with PBS, dehydrated in a
graded ethanol series and embedded in the paraffin equivalent
HistoComp (Vogel, Giessen, Germany).
Animal experiments were carried out in accordance with
animal welfare legislation and were approved by the responsible
ethics committee of the Justus-Liebig University Giessen,
Germany (permits no. II 25.3-19c20-15c GI 18/14 and VIG3-19c-
20/15 GI 18,14), and of the University of Ankara, Turkey (permits
no. Ankara 2006/06 and 2008-25-124). Samples from day 17 of
pregnancy were collected at the “Hospital Veterinário do Baixo
Vouga”, Portugal, after informed consent of the owners (22).
Total RNA Isolation, High Capacity Reverse
Transcription, Pre-amplification of cDNA,
and Semi-quantitative Real-Time TaqMan
PCR (qPCR)
Total RNA was isolated using the TRIzol reagent (Invitrogen,
Carlsbad, CA, USA) following the manufacturer’s instructions
and concentration and purity were assessed with a NanoDrop
2000C spectrophotometer (ThermoFisher scientific AG
Reinach, Switzerland). The elimination of possible genomic
DNA contamination was performed using the RQ1 RNA-free
DNase Kit (Promega, Dübendorf, Switzerland) following the
instructions provided by the manufacturer. Reverse transcription
(RT) and pre-amplification of cDNAwere performed by applying
the High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems by ThermoFisher Scientific, Foster City, CA, USA),
using 10 ng total RNA as starting material. Next, the TaqMan
PreAmp Master Mix Kit (Applied Biosystems) was applied
following the supplier’s protocols and as previously described
(25). Briefly, all used predesigned commercially available
TaqMan systems (obtained from Applied Biosystems) and
self-designed primers and 6-carboxyfluorescein (6-FAM) and
6-carboxytetramethylrhodamine (TAMRA) labeled probes
(ordered from Microsynth AG, Balgach, Switzerland), were
pooled. Afterwards, cDNA from each sample was mixed
with PreAmp Master Mix and pooled TaqMan assays and
samples were amplified in an Eppendorf Mastercycler (Vaudax-
Eppendorf AG, Basel, Switzerland). A complete list of the
predesigned TaqMan systems and self-designed primers and
6-FAM and TAMRA probes used is presented in Table 1.
The expression of the 29 selected target genes was investigated
by real-time TaqMan PCR. The construction of self-designed
primers and probes was based on published coding sequences
(CDS). For genes where only predicted CDS were available
(i.e., CD206 and NCR1), products were commercially sequenced
(Microsynth) to confirm the specificity of amplicons. Efficiency
values of PCR reactions were validated to ensure approximately
100% as previously described (25, 26). The protocols used for
sample preparation and semi-quantitative real-time TaqMan
PCR were published previously (25–27). TaqMan PCR was run
with FastStart Universal Probe Master (ROX, Roche Diagnostics
AG, Switzerland) and 5 µl pre-amplified cDNA. Reactions
were run in duplicate in an automated ABI PRISM 7500
Sequence Detection System (Applied Biosystems). Autoclaved
water and minus-RT controls were used instead of cDNA as
negative controls, and relative quantification of gene expression
was performed with the comparative Ct method (11Ct),
as previously described (26, 27). Values were calibrated to
average expression in E– samples and normalized with the
expression of reference genes. In preliminary experiments, the
expression of three potential reference genes (GAPDH, β-ACTIN
and CYCLOPHILIN) was evaluated in all used samples and
their stability values were calculated using the online tool
RefFinder (28). β-ACTIN and GAPDH were selected as more
stable than CYCLOPHILIN and used as reference genes for
11Ct evaluation.
Immunohistochemical Staining
Immunohistochemical (IHC) detection of 12 protein targets
for which commercial canine cross-reacting antibodies were
available (listed in Table 2) was performed using the standard
indirect immunoperoxidase method, following our previously
described protocol for canine tissues (27, 29). Briefly, formalin-
fixed and paraffin-embedded tissue samples were cut in 2–
3µm thick sections, mounted on microscope slides (SuperFrost;
Menzel-Glaeser, Braunschweig, Germany), deparaffinized and
rehydrated. Slides were then heated in 10mM citrate buffer (pH
6.0) in a microwave oven for antigen retrieval and endogenous
peroxidase activity was quenched with 0.3% hydrogen peroxide
diluted in methanol. Non-specific binding sites were blocked
with 10% horse or goat serum (depending on the secondary
antibody used), and samples were incubated overnight at +4◦C.
Dilutions of the selected primary antibodies are described
in Table 2. Samples were then incubated with biotin-labeled
secondary antibodies (horse anti-goat IgG BA-9500, goat anti-
rabbit IgG BA1000 or horse anti-mouse IgG BA-2000, all
purchased from Vector Laboratories Inc., Burlingame, CA,
USA), diluted 1:100 in immunohistochemistry buffer (0.8mM
Na2HPO4, 1.47mM KH2PO4, 2.68mM KCl, and 137mM
NaCl, containing 0.3% Triton X; pH 7.2–7.4), followed by the
avidin-peroxidase Vectastain ABC kit (Vector Laboratories Inc.).
Peroxidase activity was detected using a liquid DAB + substrate
kit (Dako Schweiz AG, Baar, Switzerland). Contrast staining
was performed with hematoxylin and slides were mounted
with Histokit (Assistant, Osterode, Germany). Evaluation of
primary antibodies specificity was performed by replacing
the primary antibody with a non-immune IgG from the
same species and at the same concentration (isotype control,
rabbit IgG I-1000, goat IgG I-5000, and mouse IgG I-2000,
all from Vector Laboratories Inc.). Slides were evaluated
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MHCII Major histocompatibility complex II NM_001011723.1 Forward 5′-GGA GAG CCC AAC ATC CTC ATC-3′ 90
Reverse 5′-GGT GAC AGG GTT TCC ATT TCG-3′
TaqMan probe 5′-TCG ACA AGT TCT CCC CAC C-3′
CD206/MCR1 Cluster of differentiation
206/mannose receptor C-Type 1
XM_005617091.3 Forward 5′-GGC AGG AAG ATT GTG TCG TCA T-3′ 108
Reverse 5′-TGG GCT GGG TTT GAG ATT TC-3′
TaqMan probe 5′-TGG GCA GAT CGA GCC TGC GAG-3′
NCR1 Natural cytotoxicity triggering
receptor 1
NM_001284448.1 Forward 5′-CTG GGA TCA CAC TGC CCA TAA T-3′ 103
Reverse 5′-CCT CTT CCT GCA AAG CCA GTA-3′
TaqMan probe 5′-CTT TCC TGG TCC TGA TGG CCC TCA-3′
IL1β Interleukin 1 beta NM_001037971.1 Forward 5′-TGC CAA GAC CTG AAC CAC AGT-3′ 97
Reverse 5′-CTG ACA CGA AAT GCC TCA GAC T-3′
TaqMan probe 5′-CAT CCA GTT GCA AGT CTC CCA CCA GC-3′
IL6 Interleukin 6 AF275796.1 Forward 5′-AAA GAG CAA GGT AAA GAA TCA GGA TG-3′ 124
Reverse 5′-GCA GGA TGA GGT GAA TTG TG-3′
TaqMan probe 5′-ACT CCT GAC CCA ACC ACA GAC GCC A-3′
IL8/CXCL8 Interleukin 8/ C-X-C motif
chemokine ligand 8
NM_001003200.1 Forward 5′-CCA CAC CTT TCC ATC CCA AA-3′ 114
Reverse 5′-CCA GGC ACA CCT CAT TTC CA-3′
TaqMan probe 5′-CTG AGA GTG ATT GAC AGT GGC CCA CAT TGT-3′
TNFα Tumor necrosis factor alpha NM_001003244 Forward 5′-TGC CCT TCC ACC CAT GTG-3′ 96
Reverse 5′-AGG GCT CTT GAT GGC AGA GA-3′
TaqMan probe 5′-CCC ACA CCA TCA GCC GCT TCG-3′
TNFR1 Tumor necrosis factor receptor 1 XM_849381 Forward 5′-TGT GTG GCT GCA GGA AGA AC-3′ 114
Reverse 5′-GCT TCT CTT GGC AGG AGA TCT-3′
TaqMan probe 5′-ACT CCA CCC TCT GCC TCA ATG GCA-3′
TNFR2 Tumor necrosis factor receptor 2 XM_005617982 Forward 5′-CCA GCA GAG CGA GTA CTT CGA-3′ 95
Reverse 5′-TCG AGG TCT TGG TGC AGA AGA-3′
TaqMan probe 5′-CAT GTG TCC CCC TGG CTC CCA C-3′
IDO1 Indolamin 2,3-dioxygenase 1 XM_532793.5 Forward 5′-TGA TGG CCT TAG TGG ACA CAA G-3′ 116
Reverse 5′-TCT GTG GCA AGA CTT TTC GA-3′
TaqMan probe 5′-CAG CGC CTT GCA CGT CTG GC-3′
AIF1 Allograft inflammatory factor 1 XM_532072.5 Forward 5′-CGA ATG CTG GAG AAA CTT GGT-3′ 107
Reverse 5′-TGA GAA AGT CAG AGT AGC TGAAGG T-3′
TaqMan probe 5′-TCC CCA AGA CCC ATC TGG AGC TCA A-3′
GAPDH Glyceraldehyde-3-phosphate
dehydrogenase
AB028142.1 Forward 5′-GCT GCC AAA TAT GAC GAC ATC A-3′ 75
Reverse 5′-GTA GCC CAG GAT GCC TTT GAG-3′
TaqMan probe 5′-TCC CTC CGA TGC CTG CTT CAC TAC CTT-3′
CD163 Cluster of differentiation 163 Pre-designed assay from Applied Biosystems, Prod.No. Cf02627321_m1
CD4 Cluster of differentiation 4 Pre-designed assay from Applied Biosystems, Prod.No. Cf02627842_m1
CD8 Cluster of differentiation 8 Pre-designed assay from Applied Biosystems, Prod.No. Cf02627888_m1
CD25/IL2Ra Cluster of differentiation 25/interleukin 2 receptor alpha Pre-designed assay from Applied Biosystems, Prod.No. Cf02623133_m1
FoxP3 Forkhead Box P3 Pre-designed assay from Applied Biosystems, Prod.No. Cf02741703_m1
IL10 Interleukin 10 Pre-designed assay from Applied Biosystems, Prod.No. Cf02624264_m1
IL12a Interleukin 12 Pre-designed assay from Applied Biosystems, Prod.No. Cf02628398_m1
TGFβ Transforming growth factor 1 beta Pre-designed assay from Applied Biosystems, Prod.No. Cf02623324_m1
CCL3 C-C motif chemokine ligand 3 Pre-designed assay from Applied Biosystems, Prod.No. Cf02671956_m1
CCL13 C-C motif chemokine ligand 13 Pre-designed assay from Applied Biosystems, Prod.No. Cf02622470_mH
CCR7 C-C motif chemokine receptor 7 Pre-designed assay from Applied Biosystems, Prod.No. Cf02654980_m1
TLR4 Toll-like receptor 4 Pre-designed assay from Applied Biosystems, Prod.No. Cf02622203_g1
IGF1 Insulin-like growth factor 1 Pre-designed assay from Applied Biosystems, Prod.No. Cf02627846_m1
(Continued)
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TABLE 1 | Continued
Gene Name Primer sequence
IGF2 Insulin-like growth factor 2 Pre-designed assay from Applied Biosystems, Prod.No. Cf02647136_m1
ENG Endoglin Pre-designed assay from Applied Biosystems, Prod.No. Cf02658400_m1
CDH1 Cadherin-1/epithelial cadherin (E-cadherin) Pre-designed assay from Applied Biosystems, Prod.No. Cf02624268_m1
ECM2 Extracellular matrix protein 2 Pre-designed assay from Applied Biosystems, Prod.No. Cf02641132_m1
MMP2 Matrix metalloperoteinase 2 Pre-designed assay from Applied Biosystems, Prod.No. Cf02741675_m1
β-ACTIN Beta-actin Pre-designed assay from Applied Biosystems, Prod.No. Cf03023880_g1
PPIA/Cyclophilin Peptidylprolyl isomerase A Pre-designed assay from Applied Biosystems, Prod.No. Cf03986523_gH
TABLE 2 | List of antibodies and corresponding dilutions used in
immunohistochemical staining.
Target protein Product reference and manufacturer Dilution
MHCII ORB101661 (Biorbyt, Cambridge, UK) 1:200
CD86 ORB49101 (Biorbyt, Cambridge, UK) 1:400
Nkp46 ORB157934 (Biorbyt, Cambridge, UK) 1:400
CD4 AB125711 (Abcam, Cambridge, UK) 1:400
CD8 AB101500 (Abcam, Cambridge, UK) 1:100
TNFα AB6671 (Abcam, Cambridge, UK) 1:200
TNFR1 AB19139 (Abcam, Cambridge, UK) 1:200
TNFR2 AB15563 (Abcam, Cambridge, UK) 1:200
IDO1 LS-C174759 (LSBio, Seattle, WA, USA) 1:50
AIF1 LS-B2403 (LSBio, Seattle, WA, USA) 1:400
CD206 SC-376108 (Santa Cruz Biotecnology Inc.,
Santa Cruz, CA, USA)
1:400
CD163 DB045 (DB Biotech, Kosice, SK) 1:400
qualitatively using a Leica DMRXE light microscope with a
Leica DFC425 camera (Leica Microsystems, Wetzlar, Germany).
Identification of macrophages and lymphocytes was performed
by observing positive staining against specific factors, in some
cases following staining of consecutive slides, and morphological
characterization of cells following descriptions available in the
literature (30, 31).
Statistical Analysis
Statistical evaluation of real-time TaqMan PCR was performed
using the software GraphPad 2.06 (GraphPad Software Inc,
San Diego, CA, USA). To evaluate the differences between
the analyzed groups (i.e., in response to the presence or
absence of embryos in the pre-implantation period, and between
pre-implantation, implantation, and post-implantation stages)
parametric one-way analysis of variance (ANOVA) followed
by Tukey-Kramer multiple comparisons post-test were applied.
Furthermore, the comparison between CD4 and CD8 expression
in each experimental group was performed with an unpaired
two-tailed Student’s t-test. Numerical results for relative gene
expression are presented as mean ± standard error of the mean
(SEM). P < 0.05 was considered statistically significant.
TABLE 3 | Surface markers selected for identification of macrophage and
lymphocyte subsets.
Macrophage phenotype Selected markers




T lymphocyte subpopulation Selected markers
Tc (cytotoxic) CD8
Th (helper) CD4, CD25
Treg (regulatory) CD4, CD25, FoxP3
NK (natural killer) Nkp46 (NCR1)
Selection of investigated markers was performed based on current literature (6, 32, 33,
36-40). (↑ = high expression, ↓ = low expression).
RESULTS
With the aim of characterizing the presence and localization
of several subsets of macrophages and lymphocytes in the
early pregnant canine uterus, several relevant immune system
markers, described in Table 3, were evaluated. Furthermore, the
expression of several cytokines, immune regulators, and factors
involved in tissue growth and remodeling was also assessed. The
expression of the 29 target genes was detectable in samples from
all experimental groups, although the transcript abundance of
some of them at specific stages (indicated in Figures) was low
and, sometimes, below detection limits. Among these were FoxP3
and IL12a in samples from the Post-Imp stage (Figures 1H, 3E,
respectively) and CCL13 on the day of implantation (day 17,
Figure 3K). In addition, specific staining was obtained with all
tested antibodies in all evaluated samples.
Detection of Macrophages and
Lymphocytes Markers
To investigate the presence of different macrophage phenotypes
in the canine uterus during the establishment of pregnancy,
the expression of MHCII, CD206, and CD163 was evaluated.
Pregnancy status (E+ vs. E–) and/or stage, significantly affected
the expression of transcripts encoding for MHCII (P < 0.01)
and CD206 (P < 0.0001), but no significant changes were
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FIGURE 1 | Relative gene expression of selected immune cell markers in the canine early pregnant uterus. Relative gene expression as determined by
semi-quantitative real time (TaqMan) PCR (mean ± SEM). (A–E,G–I) One-way ANOVA was applied to test the effects of time (pregnancy stage) on gene expression
revealing: P = 0.005 for MHCII, P < 0.0001 for CD206, P = 0.2 for CD163, P = 0.0032 for CD4, P = 0.06 for CD8, P = 0.02 for CD25, P = 0.01 for FoxP3 and P <
0.0001 for NCR1. In the case of P < 0.05, the analysis was followed by a Tukey-Kramer multiple comparisons post-test. (F) Comparison of relative gene expression
between CD4 and CD8 was evaluated by applying Student’s unpaired two-tailed t-test at each investigated stage. Bars with asterisks differ at: *P < 0.05, **P < 0.01,
***P < 0.001.
observed in the expression of CD163 (P > 0.05, Figure 1C).
The presence of embryos in the early pregnant uterus prior to
implantation (E+) was associated with a higher expression of
MHCII, in contrast to its non-pregnant counterparts (E–, P <
0.01, Figure 1A). This was not the case for CD206, for which
the presence of embryos had no effect on the transcript levels
(Figure 1B). However, considering the progression of pregnancy,
the expression of MHCII and CD206 was the lowest post-
implantation (Post-Imp) when compared with E+ forMHCII (P
< 0.05, Figure 1A) or all previous stages for CD206 (P < 0.001,
Figure 1B).
The different subsets of T lymphocytes were assessed by
evaluating the uterine availability of transcripts encoding for
CD4, CD8, CD25, FoxP3, and NCR1 (that encodes for NKp46).
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Significant changes in the expression of CD4 (P < 0.01), CD25
(P < 0.05), FoxP3 (P < 0.01), and NCR1 (P < 0.0001) were
observed in relation to the presence/absence of pregnancy and/or
its stage, while CD8 did not differ significantly (P > 0.05) across
all analyzed groups (Figure 1). In the early pre-implantation
period (days 8–12, E+), the presence of an embryo was associated
with increased expression ofCD4 (P< 0.01, Figure 1D),CD25 (P
< 0.05, Figure 1G), and NCR1 (P < 0.05, Figure 1I), compared
with E- samples, while FoxP3 was downregulated (P < 0.01,
Figure 1H). Regarding pregnancy stage, CD4 expression was
also the highest during pre-implantation (E+), in contrast
with the later stages, i.e., Imp and Post-Imp, when its uterine
expression was significantly suppressed (P < 0.05, Figure 1D). In
addition, CD4 expression at the E+ stage was significantly higher
than CD8 (P < 0.05, Figure 1F). As for FoxP3, although the
presence of embryos had a suppressive effect on its expression,
its expression increased during Imp (P < 0.05, Figure 1H).
Interestingly, following implantation the levels of FoxP3 mRNA
were significantly suppressed and fell below detection limits
in most of the samples (Figure 1H). Similarly, the expression
of NCR1 decreased significantly after implantation (Post-Imp),
compared with E+ and Imp (P < 0.01 and P < 0.001,
respectively, Figure 1F).
To further evaluate the immune infiltrate in the canine uterus
during the peri-implantation period, the immunolocalization
of factors selected as markers of different immune cell subsets
was also evaluated by IHC. Regarding factors expressed
by macrophages, some MHCII positive cells were observed
in the superficial layer of the endometrium of pregnant
animals during the pre-implantation stage (Figure 2A), with
a similar localization pattern observed for CD86 (Figure 2B).
Likewise, CD206-positive signals were observed in macrophages
mainly localized in superficial endometrial layers during pre-
implantation (E+, Figure 2C). However, their localization
appeared to change in subsequent stages of pregnancy, as
cells expressing CD206 could be found scattered throughout
the different layers of the endometrium and around deep
uterine glands during implantation (Figure 2D) and in Post-
Imp samples (Figure 2E). Isolated CD206-positive cells could
also be identified in the myometrium in the different pregnancy
stages (represented on Figure 2E). As for CD163, sporadic
positive cells were observed in the superficial layer of the
endometrium in pre-implantation (E+, Figure 2F) and Imp
(Figure 2G) samples, while single cells identified as macrophages
were present in the deep layers of the endometrium during
post-implantation (Figure 2H). The differentiation between
CD4-positive lymphocytes (MHCII-negative) and macrophages
(MHCII-positive) was based on cell morphology and staining
of consecutive slides against CD4 and MHCII (Figures 2I,J).
CD4-positive lymphocytes were observed within the connective
tissue in the superficial layer during the pre-implantation stage
(Figures 2I,K). Additionally, scarce cells staining positive to CD8
could also be found in the same region of the endometrium
(Figure 2L). At the time of implantation, lymphocytes expressing
CD4 were mainly localized in the superficial layer of the
endometrium (Figure 2M, top panel), with some being localized
within blood vessels (Figure 2M, bottom panel). Moreover,
staining against NKp46 was observed in numerous cells localized
mainly at the surface layer of the endometrium and around
blood vessels in pre-implantation (E+) and Imp samples
(Figures 2N,O). However, during the post-implantation stage,
NK cells were observed not only around superficial uterine glands
(Figure 2P, left panel), but also around deep uterine glands
(Figure 2P, right panel).
Cytokines and Other Immune Regulators
To further characterize the immunemilieu during the early stages
of canine pregnancy, the expression of different cytokines was
evaluated, including members of the TGF and TNF families,
chemokines, and their receptors (Figure 3). The presence of
the embryo and/or establishment of pregnancy were related to
changes in the expression of IL1β (P < 0.0001), IL6 (P <
0.0001), IL8 (P < 0.0001), IL10 (P < 0.01), IL12a (P < 0.05),
TNFR1 (P < 0.05), CCL3 (P < 0.01), and CCR7 (P < 0.01).
In contrast, TGFβ (Figure 3F), TNFα (Figure 3G), and TNFR1
(Figure 3I) were not significantly affected (P > 0.05) by time in
any of the analyzed groups. Furthermore, although no significant
changes in the expression of CCL13 were observed between
the E–, E+, and Post-Imp groups (P > 0.05), its expression
was apparently strongly suppressed at the time of implantation,
being below detection limits in several samples (Figure 3K). The
exposure of the uterus to embryos (E+) was associated with
increased expression of IL6 (P < 0.05, Figure 3B) and CCR7
(P < 0.05, Figure 3L), when compared with E– samples, while
the availability of CCL3 transcripts was significantly lower in
E+ (P < 0.05) and Post-Imp samples (P < 0.01, Figure 3J).
Implantation was associated with the highest availability of IL12a
(P < 0.01, Figure 3E), whereas its abundance was severely
affected in the Post-Imp stage as it could not be detected in several
samples (Figure 3E). This was different from what was observed
for IL1β and IL6 transcripts. Their strongly increased expression
was observed during early placentation compared with the
Imp stage (P < 0.001, Figures 3A,B, respectively). In contrast,
early pregnancy was characterized by diminishing IL8 levels,
decreasing continuously following the onset of pregnancy, during
implantation (Imp) and early placental development (Post-Imp)
(P < 0.01, Figure 3C). Similar effects were observed for IL10,
which was significantly reduced following the attachment of
embryos and Post-Imp (P < 0.05, Figure 3D). Finally, TNFR1
was downregulated during the progression of early pregnancy,
being significantly lower in Post-Imp (P < 0.05, Figure 3H)
compared with pre-implantation (E+) samples. As for CCR7,
following its upregulated levels induced by embryo presence, its
uterine levels were significantly suppressed during implantation
(P < 0.05, Figure 3L).
In addition to cytokines, the presence of other factors involved
in the uterine response to early pregnancy was assessed (TLR4,
IDO1, and AIF1, Figures 4A–C). Stage- or embryo-dependent
effects were observed in all three factors: P < 0.01 for TLR4, and
P < 0.05 for IDO1 and AIF1. The mRNA availability of TLR4
decreased dramatically and was the lowest post-implantation,
when compared with all earlier stages (P < 0.05, Figure 4A). In
contrast, IDO1 and AIF1 responded positively to the presence of
free-floating embryos (P < 0.05, Figures 4B,C); their expression
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FIGURE 2 | Immunolocalization of selected markers of macrophages and lymphocytes in the canine uterus. Immunohistochemical detection of MHCII, CD86, CD206,
CD163, CD4, CD8, and NKp46 (encoded by NCR1) at selected stages during early pregnancy. MHCII (A) and CD86 (B) were localized in individual macrophages
distributed in the superficial layer of the endometrium during pre-implantation. (C–E) CD206 signals were observed in macrophages localized in the superficial layer of
the endometrium during pre-implantation, around uterine glands (C). At the time of implantation, CD206-positive macrophages were present around uterine glands
(D, left panel), and scattered in the endometrium during implantation (D, right panel), and post-implantation period (E). Isolated cells could also be identified in the
myometrium in Post-Imp samples (E). (F–H) CD163 was expressed by macrophages detected in the superficial layer of the endometrium during pre-implantation (F)
and implantation (G). At post-implantation, single CD163-positive macrophages were localized in deep layers of the endometrium, close to the myometrium (H). To
differentiate CD4-expressing macrophages (MHCII+) and lymphocytes (MHCII−), consecutive slides were stained against CD4 (I) and MHCII (J). Both CD4 (K) and
CD8-positive lymphocytes (L) were localized in the superficial layer of the endometrium during pre-implantation. During implantation (M), individual CD4+ lymphocytes
were identified in endometrial superficial layer (top panel) and within blood vessels (bottom panel). Nkp46 (NK cells) were localized in the superficial layer of the
endometrium (N) and around blood vessels (O) during pre-implantation and implantation stages. In samples from post-implantation stage (P), NK cells were identified
around superficial (left panel) and deep uterine glands (right panel). (solid arrow = macrophages; open arrow = lymphocytes; closed arrowhead = uterine gland; open
arrowhead = blood vessel; asterisk = myometrium). No staining was observed in the isotype controls [inset in (A–C,F,I,L,N)].
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FIGURE 3 | Relative gene expression of selected cytokines in the canine uterus. (A–L) Relative gene expression as determined by semi-quantitative real time
(TaqMan) PCR (mean ± SEM). One-way ANOVA was applied, revealing: P < 0.0001 for IL1β, P < 0.0001 for IL6, P < 0.0001 for IL8, P = 0.01 for IL10, P = 0.02 for
IL12a, P = 0.16 for TGFβ, P = 0.19 for TNFα, P = 0.02 for TNFR1, P = 0.19 for TNFR2, P = 0.006 for CCL3, P = 0.083 for CCL13 and P = 0.01 for CCR7. In the
case of P < 0.05, this was followed by a Tukey-Kramer multiple comparisons post-test. Bars with asterisks differ at: *P < 0.05, **P < 0.01, ***P < 0.001.
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FIGURE 4 | Relative gene expression and localization of TLR4, IDO1 and AIF1 in the canine uterus. (A–C) Relative gene expression as determined by
semi-quantitative real time (TaqMan) PCR (mean ± SEM). One-way ANOVA was applied to test the variation among the investigated groups, revealing: P = 0.0033 for
TLR4, P = 0.03 for IDO1, and P = 0.04 for AIF1. In the case of P < 0.05, this was followed by Tukey-Kramer multiple comparisons post-test. Bars with asterisks differ
at: *P < 0.05, **P < 0.01. (D–M) Immunohistochemical localization of members of the TNF-system, IDO1, and AIF1 in the canine uterus at selected stages of early
pregnancy. Signals of TNFα were present in macrophages during the pre-implantation (D) and implantation (E) periods. Similarly, both TNFR1 (F) and TNFR2 (G,H)
were present in macrophages. In addition, weaker signals for both receptors were also observed in epithelial cells of uterine glands during pre-implantation (F,G) and
in endothelial cells (F,H). Positive signals of IDO1 were detected in macrophages between superficial glands during pre-implantation (I) and were also detected in
endothelial cells at the time of implantation (J). At post implantation, weaker signals were observed in macrophages localized in deep endometrium layers, as well as
in endothelial cells (K). AIF1 positive signals were identified in macrophages close to superficial uterine glands in pre-implantation (L) and implantation (M) stages,
while at post-implantation they were localized in the deep layer of the endometrium (N). Some weak signals were also observed in uterine glands at the
pre-implantation period (L), while apparently stronger signals were observed in the same glands at implantation (M) and post-implantation (N). Weak positive signals
were also detected in endothelial cells (M, N) (solid arrow = macrophages; closed arrowhead = uterine gland; open arrowhead = blood vessel). No staining is
observed in the isotype controls [inset in (D,F,G,I,L)].
was, however, not further affected during the establishment of
early pregnancy (P > 0.05).
The localization of different factors involved in immune
regulation, i.e., members from the TNF-system, IDO1 and AIF1,
was further evaluated (Figures 4D–N). TNFα-positive signals
were observed in cells identified as macrophages in the superficial
layer of the endometrium in pre-implantation (E+) and Imp
samples (Figures 4D,E), with some rare cells being localized
in the myometrium (not shown). As for its receptors, positive
signals for TNFR1 could be identified in immune cells localized
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around superficial glands, with weaker signals also being visible
in endothelial cells and glandular epithelial cells (Figure 4F).
Regarding TNFR2, immune cells also presented positive signals
in E+ and Imp samples (Figures 4G,H). However, only at the
time of implantation could positive staining of the endothelium
be observed (Figure 4H). Positive signals of IDO1 could be found
during the pre-implantation phase in macrophages localized
close to the luminal surface of the endometrium (Figure 4I).
At the time of implantation, additional signals for IDO1 were
present in some single cells localized within the myometrium
(not shown) as well as, to a lesser extent, in endothelial cells
(Figure 4J). Despite a similar localization pattern in Post-Imp
samples, with IDO1 signals being present in macrophages
and endothelial cells, positive signals appeared to be weaker
at this stage and macrophages were mainly localized around
deep uterine glands (Figure 4K) and within the connective
tissue of the myometrium (not shown). As for AIF1, positive
signals during pre-implantation were observed in macrophages
localized close to superficial uterine glands and in the epithelial
cells of these glands (Figure 4L). At the time of implantation,
positive signals in glandular epithelium appeared stronger than
in pre-implantation (Figure 4M). In addition, a low number
of positively stained macrophages was still observed around
the superficial glands and some weaker signals were detected
in endothelial cells (Figure 4M). Finally, in Post-Imp samples,
weak signals were observed in macrophages around deep
glands (Figure 4N), with positive staining also detected in
the epithelium of these deep glands and in endothelial cells
(Figure 4N).
IGFs and Markers of Tissue Remodeling
The uterine expression of selected factors acting as growth factors
or involved in tissue remodeling was evaluated (Figure 5). Time-
dependent effects were observed in the expression of IGF1 (P
< 0.001), IGF2 (P < 0.01), ENG (P < 0.0001), CDH1 (P <
0.001), ECM2 (P < 0.0001), and MMP2 (P < 0.05). These were
related predominantly to the stages of pregnancy as none of
these factors were significantly modulated in response to the
presence or absence of an embryo between days 8–12 (E– vs.
E+). Interestingly, following the significant induction of ENG
and CDH1 in response to embryo attachment (E+ vs. Imp, P <
0.05 and P < 0.001, respectively; Figures 5C,D), the expression
of all factors was significantly reduced after initiation of invasion
and placentation (Post-Imp) (P < 0.05, Figures 5A–F).
DISCUSSION
Considering the importance of the immune system in conceptus-
maternal communication during the establishment of pregnancy,
highlighted in several species, the lack of knowledge regarding
the dog is striking. This relates not only to the characterization of
local immune signaling, but also to the absence of information
regarding the immune cell population present in the uterus
during pregnancy. Here, by investigating the expression and/or
localization of selected markers in the dog uterus, we aimed
to determine the presence of different subsets of macrophages
and T lymphocytes known to play a role in the establishment
of pregnancy in other species. The evaluation of the expression
of different cytokines and growth factors was aimed at further
characterization of the uterine immune milieu, addressing the
functional dynamics between the implanting conceptus and
maternal structures.
The differentiation between subsets of macrophages and
lymphocytes presents several challenges, with different
phenotypes expressing similar surface markers. Thus, the
selection of a range of factors, as presented in Table 3, is
required for such differentiation. Macrophages can polarize
into M1 (classical activation, involved in the pro-inflammatory
Th1 response) and M2 (alternative activation) phenotypes,
with the latter presenting M2a (involved in the Th2 immune
response), M2b (involved in pro-inflammatory responses
and immune regulation), or M2c (tissue repair/remodeling)
characteristics (6, 32–35). Both CD86 and MHCII are expressed
in M1 and M2b macrophages, although the latter have a lower
expression of MHCII (32, 33). Thus, while the evaluation of
CD86 gene expression would not have been useful in validating
the presence of each of these two different phenotypes, the
immunohistochemical detection of MHCII allowed their
differentiation. Furthermore, the expression of CD206 and
CD163 was also investigated targeting the evaluation of
macrophages with M2a and M2c functions (32). With regard
to lymphocytes, the expression of CD8 by cytotoxic T cells is
widely recognized, while NK cells can be identified by their
production of NKp46 (encoded by NCR1) (36). Furthermore,
both activated helper (Th) and regulatory (Treg) T cells
phenotypes express CD4 and CD25 (37–40). Thus, the detection
of FoxP3, a specific marker of Treg cells, was further required
for differentiation among these cell populations (40). The
evaluation of several immune factors that can be associated
with different immune cell subsets (e.g., the expression of
TLR4 and CCR7 by M1 macrophages) further substantiated the
present analysis.
In agreement with previous findings (14, 17, 18), the presence
of the embryo was associated with the modulation of the
uterine immunemilieu during the pre-implantation period (E+).
Among the factors evaluated, the expression of MHCII, CD4,
CD25, and NCR1 was upregulated, while lower expression of
FoxP3 was observed. MHCII, which is essential for antigen
recognition by T cells, is expressed in a wide variety of
antigen presenting cells, including macrophages, monocytes, and
dendritic cells. Its expression in other endometrial cells, like
epithelial and stromal cells, has been reported in some species,
e.g., in humans and rodents (41, 42), but in the present study
positive signals were restricted to macrophages localized within
the endometrial stroma. Interestingly, these MHCII-positive
signals were colocalized with the cellular distribution of CD86-
positive cells, suggesting that the increased expression ofMHCII
in the pre-implantation period, in contrast to E- and Post-
Imp, appears to be associated with an increased infiltration of
macrophages with M1 characteristics. As for lymphocytes, the
increased expression of NCR1, a specific marker of NK cells,
suggests an increased infiltration of these cells in response to the
presence of the embryos. The potential importance of NK cells
during early pregnancy will be addressed below.
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FIGURE 5 | Relative gene expression of selected factors involved in tissue remodeling in the canine uterus. (A–F) Relative gene expression as determined by
semi-quantitative real time (TaqMan) PCR (mean ± SEM). One-way ANOVA was applied, revealing: P = 0.0007 for IGF1, P = 0.0032 for IGF2, P < 0.0001 for ENG, P
= 0.0002 for CDH1, P < 0.0001 for ECM2, P = 0.0174 for MM2. In the case of P < 0.05, this was followed by a Tukey-Kramer multiple comparisons post-test. Bars
with asterisks differ at: *P < 0.05, **P < 0.01, ***P < 0.001.
Furthermore, the increased availability of CD4 and CD25,
accompanied by a decreased expression of FoxP3, a specific
marker of Treg cells (40), appears to indicate an increased
presence of Th cells in the uterus prior to implantation. This
was further supported by the significantly higher expression
of CD4 than of the cytotoxic CD8 (43). Even though the
discrimination between Th subpopulations was not performed
in the present work, the apparently concomitantly increased
abundance of M1 and NK cell markers in the pre-implantation
period suggests the presence of a dominant Th1 immunity
in response to embryo presence. Pre-implantation was also
marked by increased expression of the anti-inflammatory IL10
and a decreased expression of the chemoattractant CCL3.
Adding to our observation of a lower expression of CD8
than CD4, this might be related to the presence of local
immunomodulatory signals involved in the immunotolerance
toward the embryo. Moreover, the canine embryo could be
also involved in modulating the uterine immune response
through the expression of factors like prostaglandin synthase 2
(PTGS2/COX2), PGE2 synthase (PTGES), and IGFs, as shown
previously (15). In particular, PGE2 appears to be of importance
for modulating the uterine immune milieu by being associated
with suppression of cytotoxic activities of local immune cells
[reviewed in (44)]. Furthermore, uterine-derived signals might
also be involved in this immunomodulatory process. As also
shown in our previous study, both IDO1 and AIF1 were
upregulated in response to embryo presence (14). IDO1 plays
a crucial role in prevention of immune-driven fetal rejection
in the mouse (45). By controlling tryptophan degradation, this
enzyme regulates leukocyte activation and is involved in a
plethora of immunomodulatory mechanisms, i.e., decreasing NK
cells cytotoxic activity, promoting Treg cell activation while
inhibiting the functions of other T cell subsets and promoting the
conversion of M1 macrophages to the M2 phenotype (46–49). In
contrast, the role of AIF1 in the uterus is still poorly understood,
but it has been associated not only with immunomodulatory
processes, but also with proliferative and vascular mechanisms
in several systems (50–53). Thus, IDO1 and AIF1 might be
involved in the modulation of immune response in the pre-
implantation period. In addition to both factors being localized
in macrophages, IDO1 positive signals were also present in
the endometrial endothelium during implantation and AIF1
expression was observed in epithelial glandular cells. Based on
this, the modulation of the inflammatory signaling observed in
the pre-implantation period appears to involve different uterine
cell populations.
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In contrast with the pre-implantation period, MHCII and
TLR4 were strongly downregulated during early placentation.
Similarly, CCR7 together with CD4 were suppressed toward
implantation and early placentation, cumulatively suggesting a
decrease in M1 activity. This decrease in M1 activity following
the establishment of pregnancy appears to reflect the situation
described previously for other species, like the human and cow,
where a shift between M1 and M2 activity is observed following
placentation (6, 54). In humans, the decrease in M1 activity
appears to be crucial for the maintenance of pregnancy, as the
imbalance in the M1/M2 macrophage population is associated
with an inadequate remodeling of uterine vascularization and
spontaneous abortion [reviewed in (6, 38)]. Following this line,
in the dog, implantation and, thus, early decidualization, was
also marked by upregulated expression of FoxP3. This suggests
an increased activity of the immunosuppressive Treg cells,
even more strongly implying the functional transition from a
proinflammatory to a modulatory immune reaction to embryo
presence, attachment, and the ongoing morpho-functional
remodeling of the uterus.While the full understanding of the role
of Treg in the uterus is still missing, a decreased number of these
cells is associated with recurrent abortions and preeclampsia in
humans, and their depletion in mice leads to pregnancy loss
(38, 39, 55). Thus, the presence of immunosuppressive Treg
cells appears to be crucial in embryo-maternal contact and could
also apply to canine reproduction. With regard to the regulation
of this immune population, PGE2 increases the expression of
FoxP3 in human peripheral CD4+CD25+ mononuclear cells
(56). Thus, by expressing PTGES (15), the implanting canine
embryo might be responsible for a local increase of PGE2
that could be involved in this increased presence of Treg cells.
Furthermore, IL12a is described as being upregulated in actively
suppressing Treg cells (57, 58), while IL6 can inhibit Treg cell
activity and FoxP3 expression (59). Thus, considering that IL12a
presented its highest expression during implantation, while IL6
was downregulated, it appears plausible that these interleukins
might be involved in the regulation of Treg cell presence in
the uterus at the time of implantation. Furthermore, besides
modulating Treg activity, IL12a is also involved in the activation
of NK cells (60, 61). As mentioned elsewhere, these cells play
a key role in the development of the decidua in humans
and mice, mainly by modulating blood vessel development
(7, 8). Following the increased expression of NCR1 observed
here in the pre-implantation and implantation periods, there
appears to be an increased number of NK cells in the uterus
during the establishment of canine pregnancy. Furthermore, the
localization of NK cells close to uterine blood vessels in the
superficial layer of the endometrium during pre-implantation
and implantation might also suggest the involvement of this
population in the modulation of uterine vascularization and
decidualization as described in other species presenting decidua
(7, 8). However, this hypothesis still needs to be verified
for the dog.
Regarding the factors involved in uterine remodeling, ENG
and CDH1 became upregulated at the time of implantation
compared with their expression in the pre-implantation uterus.
ENG acts as a TGFβ receptor and, in the murine uterus, is
associated with uterine receptivity for the implanting embryo
(62). CDH1, that encodes for E-cadherin, is an important
factor in cell adhesion and is involved in the functional
modulation of endometrial morphology and implantation in
several species [reviewed in (63)]. Thus, the increased expression
of these factors implies their involvement in the canine
implantation process.
Finally, the post-implantation period was marked by
decreased availability of markers of M1 (MHCII, TLR4) and M2a
(CD206, IL10) macrophages, T cells (CD4), NK cells (NCR1),
and an apparent decrease of the marker of Treg cells FoxP3,
in addition to other cytokines (IL8, IL12a, TNFR1). Although
the quantification of immune cells in the uterus was not
within the scope of the present work, these expression patterns
suggest a decreased immune activity in the uterus during this
period, despite the significantly increased expression of the pro-
inflammatory IL1β . We found it interesting that the localization
of CD206, CD163, and NKp46 positive cells was predominantly
associated with the superficial uterine compartments during
pre-implantation, contrasting with their increased presence
in deeper endometrial layers following early placentation, i.e.,
during the post-implantation stage. It appears that not only
the composition of the uterine immune population is affected
with the progression of pregnancy, but also its localization in
the uterus appears to change. These effects imply the presence
of immunosuppressive signals possibly required to allow the
invasion of the trophoblast during the placentation process.
Furthermore, the expression of growth factors (IGF1, IGF2)
and markers of tissue remodeling (ENG, CDH1, ECM2, and
MMP2) was decreased during the post-implantation stage, at
the time where the development of the placenta is accompanied
by significant tissue remodeling. Nevertheless, considering
that the samples analyzed in this study were derived from
implantation sites, the decreased expression of factors involved
in tissue growth and remodeling might actually reflect the
proteolytic activity of the trophoblast over the endometrium
during invasion.
Conclusions
The evaluation of several immune cell-specific markers and
other immune factors provided new insights into the uterine
immunological status and possible functional dynamics during
the early stages of canine gestation (summarized in Figure 6).
The presence of the embryo clearly modulated the uterine
milieu, inducing a controlled pro-inflammatory signaling
in the pre-implantation period. This early stage appears
to be under the influence of Th cells, that prevail over
cytotoxic lymphocytes, accompanied by an increased presence
of macrophages with proinflammatory M1 characteristics.
Furthermore, the increased presence of NK cells during the pre-
implantation and implantation periods suggests the involvement
of this population in endometrial remodeling. Interestingly, Treg
cells appear to have an important role at the time of implantation,
probably being involved in the suppression of immune responses
toward the invading embryo. To which extent the immune
system-derived factors contribute to the concomitantly occurring
Frontiers in Veterinary Science | www.frontiersin.org 13 February 2021 | Volume 7 | Article 625921
Tavares Pereira et al. Early Canine Pregnancy, Uterine Immunity
FIGURE 6 | Schematic presentation of the proposed model of immune system–mediated events in the canine uterus during establishment of pregnancy. Arrows (↑
and ↓) indicate increased or decreased expression, respectively, of different selected factors during establishment of pregnancy: pre-implantation (days 10–12),
implantation (day 17 of embryonal life), and post-implantation (day 25 of pregnancy). The presence of the free-floating embryo during pre-implantation is associated
with increased inflammatory activity, marked by upregulated expression of markers of M1 macrophages (MHCII) and Th lymphocytes (CD4, CD25). This reaction
appears to be moderated by the increased expression of immunomodulatory factors like IDO1, AIF1, and IL10. There is a shift in the immune milieu at the time of
implantation, with decreased transcripts of MHCII and increased transcripts of Treg markers (FoxP3). Both pre-implantation and implantation stages show increased
expression of the NK cell marker NCR1. During implantation, concomitantly, the first morphological signs of decidualization are observed in subepithelial endometrial
layers. The contribution of the immune system-derived factors to the decidualization process needs further clarification. In the post-implantation period, the expression
of several factors investigated is decreased at the implantation sites, indicating a decreased local immune activity in response to embryo invasion.
canine-specific decidualization, remains to be investigated. Post-
implantation proteolytic activity of the early invading trophoblast
at implantation sites appears to be associated with locally
decreased immune activity accompanied by lowered expression
of IGFs and factors involved in tissue remodeling. In the
modulation of immune responses, local factors like IDO1 and
AIF1, derived from different uterine cellular components, and
embryo-derived factors like PGE2 might be involved. Still to
be considered is the species-specific uterine exposure to high
circulating P4 levels. The immunosuppressive properties of P4
have been described in several mammals, including humans
and rodents [reviewed in (64)]. Thus, the potential role of
P4 in modulating local uterine immune responses in the dog
appears plausible and should be taken into consideration in
future research. Finally, the increased presence of NK and
Treg cells in the pre-implantation and/or implantation stages
implies similarities between the canine uterine immune milieu
and the situation observed in humans and rodents [reviewed
in (7, 8, 39)]. In fact, in our previous microarray paper, a
higher correlation of embryo-induced effects in the uterus was
observed between the dog and humans than with other domestic
mammals (14). Such similarities appear to be further linked to
the preparation of the uterus for the formation of the decidua
and, possibly, also for the placentation. However, despite sharing
the common reproductive goals of avoiding embryo rejection and
successful implantation, and taking into account the restricted
(shallow) invasion of the trophoblast during the formation of
the canine endotheliochorial placenta, there may be species-
specific regulatory features related to the local immune response
in the dog.
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